+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Fertility Test Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941118

Fertility Test Market Outlook

The global fertility test market was valued at USD 583.9 million in 2023, driven by Increasing awareness about reproductive health across the globe. The market size is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to achieve a value of USD 1124.2 million by 2032.

Fertility Test: Introduction

Fertility tests are medical assessments used to evaluate the ability to conceive in both men and women. For women, these tests often measure hormone levels, assess ovary function, and examine the condition of the uterus and fallopian tubes. For men, fertility testing primarily involves analyzing semen to evaluate sperm count, motility, and morphology. These tests are crucial for identifying fertility issues and guiding appropriate treatments or interventions for couples trying to conceive.

Key Trends in the Fertility Test Market

Increasing awareness about reproductive health and a trend towards delayed parenthood, often for career or financial reasons, have led to a growing demand for fertility tests.

There's a surge in the development of advanced, user-friendly fertility monitoring devices and digital apps, allowing individuals and couples to track fertility windows and hormonal changes conveniently at home.

Over the counter and direct-to-consumer fertility tests are becoming more popular, offering privacy and convenience without the need for a clinical visit.

Holistic Approach to Fertility Health: There's a growing emphasis on understanding the broader aspects of fertility health, not just conception. This includes hormone health, menstrual cycle tracking, and preconception planning.

Clinics and healthcare providers are increasingly integrating fertility testing with comprehensive counseling and support services, addressing both the physical and emotional aspects of fertility.

The market is witnessing an increased focus on male fertility issues, with more products and services aimed at assessing and improving male reproductive health.

While developed markets show a trend towards early and sophisticated fertility assessments, emerging markets are gradually catching up, with increasing access to education and fertility health services.

Global Fertility Test Market Segmentation

Market Breakup by Products

  • Ovulation Predictor Kits
  • Fertility Monitors
  • Urine
  • Saliva
  • Blood

Market Breakup by Application

  • Male
  • Female

Market Breakup by End User

  • Home Care
  • Fertility Clinics
  • Hospitals

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan

Fertility Test Market Overview

North America shows a high demand for fertility tests, driven by advanced healthcare infrastructure, high awareness about reproductive health, and a significant prevalence of fertility-related issues. The U.S. and Canada have a substantial market for both at-home and clinical fertility testing products.

Europe is characterized by widespread availability and acceptance of fertility testing services, with countries like the UK, Germany, and France leading in the adoption of advanced testing technologies. There's a strong focus on offering comprehensive fertility assessments and personalized treatment plans.

Asia-Pacific is experiencing rapid growth, especially in countries like China, Japan, and India. Factors contributing to this growth include rising awareness about fertility issues, increasing healthcare expenditure, and changing lifestyles. However, cultural attitudes towards fertility and societal norms can affect the adoption of fertility tests.

Latin America market is developing, with increasing access to healthcare services and growing awareness about fertility treatments. Countries like Brazil and Mexico are seeing a gradual increase in the demand for fertility testing and assisted reproductive technologies.

Middle East & Africa is an emerging market with increasing investment in healthcare infrastructure and a growing demand for reproductive health services. The region shows potential for growth, though cultural and regulatory factors can influence the adoption and availability of fertility tests.

Fertility Test Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Swiss Precision Diagnostics
  • Church & Dwight Co., Inc.
  • Prestige Brands Holdings
  • bioZhena
  • Fairhaven Health
  • Fertility Focus
  • Geratherm Medical AG
  • Hilin Life Products
  • UEBE Medical
  • Churchill Pharmaceuticals, LLC.
  • Procter & Gamble Co.
  • Mankind Pharma Ltd.
  • Babystart Ltd.
  • Innevation Pty Ltd.
  • AdvaCare Pharma


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Fertility Test Market Overview
3.1 Global Fertility Test Market Historical Value (2017-2023)
3.2 Global Fertility Test Market Forecast Value (2024-2032)
4 Global Fertility Test Market Landscape
4.1 Fertility Test: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Fertility Test: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Fertility Test Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Fertility Test Market Segmentation
6.1 Global Fertility Test Market by Products
6.1.1 Market Overview
6.1.2 Ovulation Predictor Kits
6.1.3 Fertility Monitors
6.1.3.1 Urine
6.1.3.2 Saliva
6.1.3.3 Blood
6.2 Global Fertility Test Market by Application
6.2.1 Market Overview
6.2.2 Male
6.2.3 Female
6.3 Global Fertility Test Market by End User
6.3.1 Market Overview
6.3.2 Home Care
6.3.3 Fertility Clinics
6.3.4 Hospitals
6.4 Global Fertility Test Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Fertility Test Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Fertility Test Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Fertility Test Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Fertility Test Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Fertility Test Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Swiss Precision Diagnostics
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Church & Dwight Co., Inc.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Prestige Brands Holdings
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 bioZhena
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Fairhaven Health
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Fertility Focus
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Geratherm Medical AG
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Hilin Life Products
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 UEBE Medical
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Churchill Pharmaceuticals, LLC.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Procter & Gamble Co.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Mankind Pharma Ltd.
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 Babystart Ltd.
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Innevation Pty Ltd.
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 AdvaCare Pharma
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Swiss Precision Diagnostics
  • Church & Dwight Co. Inc.
  • Prestige Brands Holdings
  • bioZhena
  • Fairhaven Health
  • Fertility Focus
  • Geratherm Medical AG
  • Hilin Life Products
  • UEBE Medical
  • Churchill Pharmaceuticals LLC.
  • Procter & Gamble Co.
  • Mankind Pharma Ltd.
  • Babystart Ltd.
  • Innevation Pty Ltd.
  • AdvaCare Pharma

Methodology

Loading
LOADING...

Table Information